NCT03918109: A trial that was reported late by Otonomy, Inc.
This trial has reported, although it was 529 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03918109 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled Phase 1/2 Study of OTO-313 Given as a Single Intratympanic Injection in Subjects With Subjective Tinnitus |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 4, 2019 |
| Completion date | May 29, 2020 |
| Required reporting date | May 29, 2021, midnight |
| Actual reporting date | Nov. 9, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 529 |